Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Tirzepatide for Sale > Tirzepatide |GLP-1 Peptides GIP GCG | 99% Purity | 10mg 15mg 20mg 60mg Vials | Lyophilized Powder
Tirzepatide |GLP-1 Peptides GIP GCG | 99% Purity | 10mg 15mg 20mg 60mg Vials | Lyophilized Powder buy - large image1
Tirzepatide |GLP-1 Peptides GIP GCG | 99% Purity | 10mg 15mg 20mg 60mg Vials | Lyophilized Powder buy - image1

Tirzepatide |GLP-1 Peptides GIP GCG | 99% Purity | 10mg 15mg 20mg 60mg Vials | Lyophilized Powder

2103 Inquiries

Unit Price: Get Latest Price
CAS No.:

2023788-19-2

Grade:

Pesticide Grade

Content:

99%

Port:

ShenZhen

Brand:

ZYSG-Synpeptide

Packaging:

Vial/Bottle/Bag/Carton

Sample Available:

Yes

Price valid (until):

2026-03-20

Company Type:
Trader
Location:
China
Average Lead Time:
7 days
Qualification:
Main Products:

Semaglutide,Retatrutide,Tirzepatide,Cagrilintide,GHK-Cu,peptides

  • Product Details

  • Seller Information

  • Inquiry History

  • Description

    Business Type: Manufactory

    Name: Cynthia

    WhatsApp: +852 5279 8767

    Email:healthy.dongfang@gmail.com

    Shop Tirzepatide |GLP-1 Peptides GIP GCG | 99% Purity | 10mg 15mg 20mg 60mg Vials | Lyophilized Powder-Detailed Image 1  






    ——Product Detail  ——


    Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist.

    This medication is designed to improve glycemic control in people with type 2 diabetes by targeting both the GIP and GLP-1 receptors. By stimulating these receptors, tirzepatide can increase insulin secretion and decrease glucagon secretion in a glucose-dependent manner, helping to lower blood sugar levels.

    Clinical trials have shown promising results in terms of reducing HbA1c levels and body weight in individuals with type 2 diabetes. Tirzepatide is being studied in various dosages and formulations to determine its effectiveness, safety, and potential benefits for people with diabetes

    NOTE: This product was prepared by chemical synthesis. Used only for research. Not for human use.

    Shop Tirzepatide |GLP-1 Peptides GIP GCG | 99% Purity | 10mg 15mg 20mg 60mg Vials | Lyophilized Powder-Detailed Image 2

    Shop Tirzepatide |GLP-1 Peptides GIP GCG | 99% Purity | 10mg 15mg 20mg 60mg Vials | Lyophilized Powder-Detailed Image 3



     

    ——FAQ——

    Q1. How do you ensure product quality?
    A: We have a strict quality management system, all batches must be tested and meet our standards before entering the warehouse. The purity of all our products is above 99.00%, which has been verified by many American and European customers.


    Q2. How to place an order with you?
    A: After confirming the dosage/strength and quantity of the required product with the customer, our business personnel will make a Proforma Invoice or Sales Contract. After the customer confirms and pays for the order, we will arrange shipment for the customer as soon as possible.


    Q3. What payment methods are there?
    A: There are Bank Transfer, PayPal, Tether USD(USDT) and Bitcoin(BTC); we can also accept payments in CNY, for example, through Alipay or WeChat.


    Q4. What shipping methods can we choose?
    A: Usually express delivery is more suitable, including DHL, FedEx, UPS, etc. For Russia, we also have a dedicated express channel (double customs clearance). We will be responsible for customs clearance in the destination country, and customers are not required to cooperate with customs clearance and pay any tariffs.



    Shop Tirzepatide |GLP-1 Peptides GIP GCG | 99% Purity | 10mg 15mg 20mg 60mg Vials | Lyophilized Powder-Detailed Image 4

    These products are APIs (Active Pharmaceutical Ingredient) and not a finished drug. 

    It is intended strictly for research and laboratory use only.

    Buyers are required to fully comply with all applicable laws and regulations regarding the handling and use of this material.


    Items Specifications
    Tirzepatide 5mg/10mg/15mg/20mg/30mg/40mg/50mg/60mg/100/mg




    ECHEMI Editorial Reference

    Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.

    Basic Info
    Product Name:

    Tirzepatide

    Other Name:

    LY3298176;

    CAS No.:

    2023788-19-2

    Molecular Formula:

    C225H348N48O68

    Molecular Weight:

    4813

    EC Number:

    200-001-8

    Characteristics
    Appearance:

    White to off-white

    Research
    Class:

    Dual agonist — GIPR, GLP-1R

    Status:

    FDA-approved (Mounjaro / Zepbound)

    Mechanism:

    Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.

    EC50 (Human GLP1R):

    0.934 nM

    EC50 (Human GIPR):

    0.0224 nM

    Source:

    Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI

    FDA:

    Mounjaro, Zepbound (approved 2022-05-13)

    References
    ChEMBL:

    CHEMBL4297839

    DrugBank:

    DB15171

    KEGG DRUG:

    D11360

    PubChem:

    PubChem

    Disclaimer:

    Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Semaglutide,Retatrutide,Tirzepatide,Cagrilintide,GHK-Cu,peptides

    Location:

    zhiyushiguang

    Average lead Time:

    7 days

    Total Annual Revenue:

    $5 million-$10 million

    Total Employees:

    11-50

    Year of Establishment:

    2024

  • Inquiry History
    2103 Inquiries
    Country Product Purchase Quantity Date Posted
    Brazil

    Tirzepatide

    100 G Oct 28, 2026
    Belgium

    Tirzepatide

    10 MG Oct 28, 2026
    United States

    tirzepatide

    100 MG Oct 28, 2026
    United States

    Tirzepatide

    60 MG Oct 28, 2026
    United States

    Tirzepatide

    10 PCS Oct 28, 2026
    United States

    tirzepatide

    30 MG Oct 27, 2026
    United States

    Tirzepatide

    40 MG Oct 27, 2026
    Philippines

    Tirzepatide

    2 MT Oct 27, 2026
    Philippines

    Tirzepatide

    30 MG Oct 26, 2026
    Slovakia

    Tirzepatide

    1 G Oct 26, 2026
    France

    Tirzepatide

    1 KG Oct 25, 2026
    United States

    Tirzepatide

    2.5 MG Oct 25, 2026
    United Kingdom

    Tirzepatide

    5 MT Oct 25, 2026
    United Kingdom

    Tirzepatide

    6 MT Oct 24, 2026
    Peru

    tirzepatide

    10 MG Oct 21, 2026
    Puerto Rico

    tirzepatide

    40 MG Oct 21, 2026
    United States

    Tirzepatide

    10 MT Oct 21, 2026
    South Africa

    Tirzepatide

    1 MT Oct 20, 2026
    United States

    Tirzepatide

    5 KG Oct 20, 2026
    United States

    tirzepatide

    30 MG Oct 20, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.